Movement disorders in valine métabolism diseases caused by HIBCH and ECHS1 deficiencies

Marie-Céline François-Heude1, Elise Lebigot2, Emmanuel Roze3

  • 1CHU Montpellier, Département de Neuropédiatrie, Univ Montpellier, Montpellier, France.

Insights

3-hydroxyisobutyryl-coenzyme A (CoA) hydrolase (HIBCH) and short-chainenoyl-CoA hydratase (ECHS1) deficiencies cause rare metabolic disorders with neurological symptoms. This study details the movement disorder spectrum in affected patients, finding dystonia to be the most common manifestation.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • 3-hydroxyisobutyryl-coenzyme A (CoA) hydrolase (HIBCH) and short-chainenoyl-CoA hydratase (ECHS1) enzymes are crucial for valine catabolism.
  • Deficiencies in HIBCH (HIBCHD) and ECHS1 (ECHS1D) lead to rare metabolic disorders often presenting with neurological symptoms.

Purpose of the Study:

  • To characterize the spectrum of movement disorders (MDs) in patients with pathogenic variants in the ECHS1 and HIBCH genes.
  • To analyze the clinical phenotypes of HIBCHD and ECHS1D, focusing on movement disorder manifestations.

Main Methods:

  • Retrospective review of 18 patients (5 HIBCHD, 13 ECHS1D) with detailed phenotype analysis.
  • Inclusion of 105 additional patients from existing literature for a comprehensive analysis (38 HIBCHD, 85 ECHS1D).

Main Results:

  • Both HIBCHD and ECHS1D exhibit similar neurological phenotypes with early onset (before 10 years) and varied presentations like neonatal onset, Leigh-like syndrome, and paroxysmal dyskinesia.
  • Movement disorders were prevalent, affecting 61% of HIBCHD and 72% of ECHS1D patients, with dystonia being the most frequent type.
  • Paroxysmal dyskinesia cases often presented with pure dystonia and normal development; no genotype-phenotype correlation was identified for MDs.

Conclusions:

  • Movement disorders, including abnormal eye movements, are a key feature of HIBCHD and ECHS1D.
  • The spectrum of MDs is diverse, frequently involves dystonia, and can present as a combination of different movement disorder types in a single patient.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
225
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
560
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
15.2K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.2K
Disorders of Acid-Base Balance01:29

Disorders of Acid-Base Balance

The human body maintains a precise pH range of arterial blood between 7.35 and 7.45. Deviations result in either acidosis (pH < 7.35) or alkalosis (pH > 7.45). These conditions are further classified as respiratory or metabolic disorders based on their underlying cause.
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...
418